Credit Agricole S A Portage Biotech Inc. Transaction History

Credit Agricole S A

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$13.65 - $22.4 $18,427 - $30,239	1,350 New	1,350 $27,000
Q2 2021 Aug 10, 2021	SELL	$20.96 - $42.81 $9,432 - $19,264	-450 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$17.55 - $39.5 $7,897 - $17,775	450 New	450 $13,000

28.4K

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $82.9M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.